The Thierry Latran Foundation 12th Call for projects opened in December 2019 The Thierry Latran Foundation was established in 2008 to a) finance basic, applied and clinical research with potential therapeutic benefit in sporadic ALS (Amyotrophic Lateral Sclerosis) and b)...
The Thierry Latran Foundation 11th Call for projects opened in October 2018 The Thierry Latran Foundation was established in 2008 to a) finance basic, applied and clinical research with potential therapeutic benefit in sporadic ALS (Amyotrophic Lateral Sclerosis) and b)...
12th Call for Projects The Thierry Latran Foundation was established in 2008 to a) finance basic, applied and clinical research with potential therapeutic benefit in sporadic ALS (Amyotrophic Lateral Sclerosis) and b) to support academic and industrial scientific research...
The Thierry Latran Foundation 10th Call for projects opened in December 2017 The Thierry Latran Foundation was established in 2008 to a) finance basic, applied and clinical research with potential therapeutic benefit in sporadic ALS (Amyotrophic Lateral Sclerosis) and...
11th Call for Projects The Thierry Latran Foundation was established in 2008 to a) finance basic, applied and clinical research with potential therapeutic benefit in sporadic ALS (Amyotrophic Lateral Sclerosis) and b) to support academic and industrial scientific research...
The Thierry Latran Foundation 9th Call for projects opened in November 2016 to finance research with potential therapeutic benefit in sporadic ALS on the following themes: Biological markers, pathological pathways and mechanisms, therapeutic strategies, innovative molecules in the fields...
Publication of the project : EphA4 inhibition as a therapeutic strategy for ALS This project selected in 2013 was a continuation of the project selected in 2009 entitled : “Translational Research into the role of the ephrin receptor EphA4...
The Thierry Latran Foundation 8th Call for projects opened in November 2015 to finance research with potential therapeutic benefit in sporadic ALS on the following themes: Biological markers, pathological pathways and mechanisms, therapeutic strategies, innovative molecules in the fields...
Date Revue Principal investigator Year april-23 Acta Neuropathol Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosis L. Dupuis, France 2019 march-23 EBioMedicine Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers L. Dupuis, France 2019...
The Thierry Latran Foundation was established in 2008 to a) finance basic, applied and clinical research with potential therapeutic benefit in sporadic Amyotrophic Lateral Sclerosis and b) to support academic and industrial scientific research efforts in Europe to cure...